Rxivo, LLC launched its next venture globally.

Rxivo connects telehealth providers and medical practices with FDA-registered 503B and 503A compounding pharmacies, delivering pharmaceutical excellence at scale. We've eliminated the complexity of sourcing high-quality compounded medications, enabling healthcare providers to focus on patient care while we handle the rest. Whether you're a telehealth startup or a nationwide franchise operation, Rxivo scales with your needs. Our streamlined model serves telehealth platforms specializing in ED medications, weight loss and GLP-1 therapies, TRT, and IV products for primary care, as well as medical practice franchises and independent physician groups. We specialize in connecting providers with high-demand therapeutic categories where quality and reliability matter most: weight management, hormone optimization, sexual wellness, mental health, and regenerative medicine. Every product comes from FDA-registered facilities maintaining the highest manufacturing standards. Quality is assured through exclusive partnerships with FDA-registered 503B facilities. Supply reliability with consistent availability. Simplified operations through a single-source solution. Compliance confidence with cGMP manufacturing standards. Scalability with infrastructure that grows with your practice. Founded by pharmaceutical and healthcare veterans with deep expertise in biotech, telehealth markets, and distribution logistics, Rxivo brings over 30 years of industry experience to modern healthcare's pharmaceutical challenges. Ready to Scale? Let's discuss how we can support your growth.